226 related articles for article (PubMed ID: 25342391)
1. The role of genome sequencing in personalized breast cancer prevention.
Sieh W; Rothstein JH; McGuire V; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2322-7. PubMed ID: 25342391
[TBL] [Abstract][Full Text] [Related]
2. Ability to predict breast cancer in Asian women using a polygenic susceptibility model.
Hartman M; Suo C; Lim WY; Miao H; Teo YY; Chia KS
Breast Cancer Res Treat; 2011 Jun; 127(3):805-12. PubMed ID: 21153878
[TBL] [Abstract][Full Text] [Related]
3. Genomic medicine and risk prediction across the disease spectrum.
Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
[TBL] [Abstract][Full Text] [Related]
4. ["Screening" in special situations. Assessing predictive genetic screening for hereditary breast and colorectal cancer].
Jonas S; Wild C; Schamberger C
Z Arztl Fortbild Qualitatssich; 2003 Feb; 97(1):67-71. PubMed ID: 12669692
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer prevention based on gene-environment interaction.
Song M; Lee KM; Kang D
Mol Carcinog; 2011 Apr; 50(4):280-90. PubMed ID: 21465576
[TBL] [Abstract][Full Text] [Related]
6. Polygenic susceptibility to breast cancer and implications for prevention.
Pharoah PD; Antoniou A; Bobrow M; Zimmern RL; Easton DF; Ponder BA
Nat Genet; 2002 May; 31(1):33-6. PubMed ID: 11984562
[TBL] [Abstract][Full Text] [Related]
7. Personalized assessment and management of women at risk for breast cancer in North America.
Pruthi S; Heisey R; Bevers T
Womens Health (Lond); 2015 Mar; 11(2):213-23; quiz 223-4. PubMed ID: 25776295
[TBL] [Abstract][Full Text] [Related]
8. Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
Lerner-Ellis J; Khalouei S; Sopik V; Narod SA
Expert Rev Anticancer Ther; 2015; 15(11):1315-26. PubMed ID: 26523341
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics driving personalized medicine: analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations.
Cocca M; Bedognetti D; La Bianca M; Gasparini P; Girotto G
J Transl Med; 2016 Jan; 14():22. PubMed ID: 26801900
[TBL] [Abstract][Full Text] [Related]
10. Mathematical modeling for breast cancer risk assessment. State of the art and role in medicine.
Rubinstein WS; O'Neill SM; Peters JA; Rittmeyer LJ; Stadler MP
Oncology (Williston Park); 2002 Aug; 16(8):1082-94; discussion 1094, 1097-9. PubMed ID: 12201647
[TBL] [Abstract][Full Text] [Related]
11. Replication of genome-wide discovered breast cancer risk loci in the Cypriot population.
Loizidou MA; Hadjisavvas A; Ioannidis JP; Kyriacou K
Breast Cancer Res Treat; 2011 Jul; 128(1):267-72. PubMed ID: 21210208
[TBL] [Abstract][Full Text] [Related]
12. The impact of next generation sequencing on the analysis of breast cancer susceptibility: a role for extremely rare genetic variation?
Hilbers FS; Vreeswijk MP; van Asperen CJ; Devilee P
Clin Genet; 2013 Nov; 84(5):407-14. PubMed ID: 24025038
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment.
Kurian AW; Kingham KE; Ford JM
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):23-33. PubMed ID: 25502425
[TBL] [Abstract][Full Text] [Related]
14. A role for common genomic variants in the assessment of familial breast cancer.
Sawyer S; Mitchell G; McKinley J; Chenevix-Trench G; Beesley J; Chen XQ; Bowtell D; Trainer AH; Harris M; Lindeman GJ; James PA
J Clin Oncol; 2012 Dec; 30(35):4330-6. PubMed ID: 23109704
[TBL] [Abstract][Full Text] [Related]
15. Screening and prevention of breast cancer in primary care.
Tice JA; Kerlikowske K
Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
[TBL] [Abstract][Full Text] [Related]
16. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery.
Roukos DH
Expert Rev Mol Diagn; 2008 Sep; 8(5):587-97. PubMed ID: 18785807
[TBL] [Abstract][Full Text] [Related]
17. Genetic susceptibility, predicting risk and preventing cancer.
Pharoah PD
Recent Results Cancer Res; 2003; 163():7-18; discussion 264-6. PubMed ID: 12903839
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C
JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675
[TBL] [Abstract][Full Text] [Related]
19. 'A low risk is still a risk': exploring women's attitudes towards genetic testing for breast cancer susceptibility in order to target disease prevention.
Henneman L; Timmermans DR; Bouwman CM; Cornel MC; Meijers-Heijboer H
Public Health Genomics; 2011; 14(4-5):238-47. PubMed ID: 20090298
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
